Not exact matches
Past -
month e-
cigarette use predicted future conventional
cigarette use across 3 longitudinal waves among high school youth.
Last
month, legislators unveiled a plan to ban the
use of e-
cigarettes in indoor workplaces, similar to the ban on traditional
cigarettes.
When the researchers looked at whether alcohol,
cigarette, and marijuana
use predicted suicidality, they found that for all racial groups, except Pacific Islanders,
using alcohol in the past
month was linked to 1.5 - 2.1 times greater odds for having attempted suicide in the past year.
When
cigarette use in the past
month was examined, adolescents from every racial group, including whites, had even higher odds for attempting suicide in the past year ranging from 2.1 - 2.7, suggesting a link between these problem behaviors.
Of participants who said they vaped e-
cigarettes in the first questionnaire, 47.7 percent had started smoking
cigarettes 18
months later, compared to 10.2 percent of those who did not
use e-
cigarettes.
Young adults who
use electronic
cigarettes are more than four times as likely to begin smoking tobacco
cigarettes within 18
months as their peers who do not vape, according to new University of Pittsburgh research.
In 2013, around 2.5 % of people across the country reported having
used the devices in the past
month; among adolescents, e-
cigarettes are now
used more than conventional
cigarettes, said the US Centers for Disease Control and Prevention in April this year.
Contrary to advertiser claims that e-
cigarettes can help consumers stop smoking conventional
cigarettes, teenagers who
used e-
cigarettes and conventional
cigarettes were much less likely to have abstained from
cigarettes in the past 30 days, 6
months, or year.
Among
cigarette smokers not willing or able to quit smoking in the next
month but willing to reduce with the goal of quitting in the next 3
months,
use of the nicotine addiction medication varenicline for 24 weeks compared with placebo produced greater reductions in smoking prior to quitting and increased smoking cessation rates at the end of treatment and at 1 year, according to a study in the February 17 issue of JAMA.
An analysis of data from a previous study of more than 1,350 smokers intending to quit after a hospitalization found that those who reported
using electronic
cigarettes (e-
cigarettes) during the study period were less likely to have successfully quit smoking 6
months after entering the study.
22Benedum C.M. et al. (2013) Risk of spina bifida and maternal
cigarette, alcohol, and coffee
use during the first
month of pregnancy.
Seeing a parent drunk dramatically increases the likelihood that a teenager will drink,
use marijuana, or smoke
cigarettes, according to a national survey released last
month.
Even if you do only smoke a few
cigarettes a day you will be classed as a smoker and you will usually be asked whether you have
used any tobacco products in the previous twelve
months, although if you only smoke the occasional pipe, cigar or
cigarette on special occasions this will be taken into account and you may even be able to find a life insurance provider who is actually prepared to give you non-smoker rates.
• No
cigarette use within 12
months • Cholesterol of 300 or less with or without medication • Blood pressure of 140/90 with or without medication • Some minor health issues • No more than 40 - 50 pounds overweight
This was assessed via 3 measures: (1) parental
cigarette smoking (for the
month before assessment) at the 5 -, 6 -, and 9 - year follow - up; (2) parental alcohol problems, based on questions from the Composite International Diagnostic Inventory35 relating to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition36 alcohol abuse / dependence symptom criteria, in the 12
months before the 5 -, 6 -, and 9 - year follow - up; and (3) parental
use of cannabis or other illicit drugs, since the previous assessment, at the 5 -, 6 -, and 9 - year follow - up.
Assessments conducted at earlier phases are specified in previous articles.7, 8 At the 15 - year follow - up assessment, adolescents completed interviews that measured whether they had been adjudicated a person in need of supervision (PINS) resulting from incorrigible behavior such as recurrent truancy or destroying parents» property; their frequency of running away from home; and the number of times they had been stopped by the police, arrested, convicted of a crime or of probation violations, and sent to youth correctional facilities.14 They also reported on their disruptive behavior in school; number of school suspensions; delinquent and aggressive behavior outside school; experience of sexual intercourse; rates of pregnancy; lifetime number of sexual partners; and frequency of
using cigarettes, alcohol, and illegal drugs during the 6 -
month period prior to the 15 - year interview.15
The risk items investigated included sexual intercourse, condom
use in the last sexual encounter (limited to youths who were sexually active), fighting, beating up someone, smoking
cigarettes, consuming alcoholic beverages,
using marijuana, selling drugs, and delivering drugs during the previous 6
months.
At 12
months after intervention, again controlling for baseline differences, rates of alcohol and marijuana
use were significantly lower and
cigarette use and overall risk intention were marginally lower among FOK plus ImPACT youths compared with FOK only youths.
At 6
months» follow - up, youths in families that were assigned to FOK plus ImPACT reported significantly lower rates of sexual intercourse, sex without a condom, alcohol
use, and
cigarette use and marginally lower rates of «risky sexual behavior» compared with youths in families that were assigned to FOK only.
Smoking cessation at the end of treatment and at 6
months after the start of treatment: measured by self - report and / or biochemical verification (expired carbon monoxide (CO) level); reduction in nicotine dependence at the end of treatment and at 6
months (measured by change in expired CO level and self - reported number of
cigarettes smoked, and other biochemical measurements such as serum cotinine levels); change in positive, negative and depressive symptoms at the end of treatment measured
using validated tools; adverse events.